Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OC000459 in moderate to severe atopic dermatitis
2013-001924-20Phase 2Completed
- Sponsor
- Atopix Therapeutics
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in atopic dermatitis (AD) comparing OC000459 with Placebo (2 arms). Started May 2013; status: completed.
02
Drugs
timapiprant
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2013-001924-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001924-20.